|
|
||||||||
USAF Medical Center, Scott AFB, Illinois
Correspondence: For reprints contact: William C. Klingensmith III, Division of Nuclear Medicine, The Johns Hopkins Medical Institutions, 615 N. Wolfe St., Baltimore, Md. 21205.
ABSTRACT
Increased splenic uptake of 99mTc-sulfur colloid (TcSC) in patients with malignant melanoma and no evidence of liver disease has recently been reported. In a similar patient serial liverspleen studies demonstrated the resolution of splenomegaly and increased splenic uptake of TcSC following the surgical removal of a malignant melanoma of the eye.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |